Le T - Search Results

1

Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?

Le T, Krepart GV, Lotocki RJ, Heywood MS. Le T, et al. Gynecol Oncol. 1999 Aug;74(2):252-4. doi: 10.1006/gyno.1999.5440. Gynecol Oncol. 1999. PMID: 10419740

2

Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.

Le T, Krepart GV, Lotocki RJ, Heywood MS. Le T, et al. Gynecol Oncol. 1997 May;65(2):237-40. doi: 10.1006/gyno.1997.4625. Gynecol Oncol. 1997. PMID: 9159331

3

Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?

Le T, Krepart GV, Lotocki RJ, Heywood MS. Le T, et al. Gynecol Oncol. 1997 Nov;67(2):208-14. doi: 10.1006/gyno.1997.4839. Gynecol Oncol. 1997. PMID: 9367710

4

Early ovarian cancer: what is the staging impact of retroperitoneal node sampling?

Faught W, Le T, Fung Kee Fung M, Krepart G, Lotocki R, Heywood M. Faught W, et al. Among authors: le t. J Obstet Gynaecol Can. 2003 Jan;25(1):18-21. doi: 10.1016/s1701-2163(16)31078-7. J Obstet Gynaecol Can. 2003. PMID: 12548321

5

Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer.

Le T, Hopkins L, Kee Fung MF. Le T, et al. Gynecol Oncol. 2005 Jul;98(1):39-44. doi: 10.1016/j.ygyno.2005.03.040. Gynecol Oncol. 2005. PMID: 15907986

6

Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.

Le T, Williams K, Senterman M, Hopkins L, Faught W, Fung-Kee-Fung M. Le T, et al. Gynecol Oncol. 2007 Jul;106(1):160-3. doi: 10.1016/j.ygyno.2007.03.029. Epub 2007 May 9. Gynecol Oncol. 2007. PMID: 17490737

7

Recurrent metastatic fallopian tube carcinoma in pregnancy.

Adolph A, Le T, Khan K, Biem S. Adolph A, et al. Among authors: le t. Gynecol Oncol. 2001 Apr;81(1):110-2. doi: 10.1006/gyno.2000.6097. Gynecol Oncol. 2001. PMID: 11277660

8

Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer.

Le T, Hopkins L, Baines KA, Rambout L, Al Hayki M, Kee Fung MF. Le T, et al. Gynecol Oncol. 2006 Jul;102(1):49-53. doi: 10.1016/j.ygyno.2005.11.025. Epub 2005 Dec 20. Gynecol Oncol. 2006. PMID: 16375951 Clinical Trial.

9

The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.

Le T, Hopkins L, Faught W, Fung-Kee-Fung M. Le T, et al. Gynecol Oncol. 2007 Jun;105(3):712-5. doi: 10.1016/j.ygyno.2007.02.022. Epub 2007 Apr 2. Gynecol Oncol. 2007. PMID: 17400284

10

Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?

Le T, Latifah H, Jolicoeur L, Weberpals J, Faught W, Hopkins L, Fung MF. Le T, et al. Gynecol Oncol. 2011 Jun 1;121(3):451-4. doi: 10.1016/j.ygyno.2011.02.016. Epub 2011 Mar 12. Gynecol Oncol. 2011. PMID: 21402403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,208 results

Search Page

Filters